CN
|
EN
Home
Introduction to the 2024 CBIIC
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Previous Speakers
News
Expert
Organizations
Service
Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Non-Listed Company Roadshow
Agendas
14:00 - 17:20
非上市公司路演专场
Non-Listed Company Roadshow
Moderator
贺菊颖 , 中信建投证券医药行业首席分析师
HE Juying , Head of Healthcare Equity Research at China Securities
14:00 - 14:20
项目1
Project 1
全球首创24价双载体蛋白肺炎结合疫苗的开发和产业化
Development of A Novel 24 Valent Pneumococcal Conjugate Vaccine with Dual Carrier Proteins Against Pneumococcal Diseases
祝先潮 上海瑞宙生物科技有限公司创始人、总经理、首席科学官
Jeff ZHU , Founder, CEO, CSO, Shanghai Reinovax Biologics Co., Ltd.
14:20 - 14:40
项目2
Project 2
成都柏奥特克——聚焦成熟大苗市场的新一代疫苗开发领军企业
Chengdu Boaovax - A New Generation of Vaccine Developer Focusing on the Mature Vaccine Market
梁智杰 成都柏奥特克生物科技股份有限公司总经理
Colin LIANG , CEO, BOAOVAX INC.
14:40 - 15:00
项目3
Project 3
溶瘤病毒OH2注射液激活淋巴细胞治疗恶性胸腹水转化研究
Oncolytic Virus OH2 Injection Activates Lymphocytes to Treat Malignant Pleural and Ascites Fluid Conversion Research
汪洋 武汉滨会生物科技股份有限公司副总经理
WANG Yang , Vice General Manager, Binhui Biopharmaceutical Co., Ltd.
15:00 - 15:20
项目4
Project 4
下一代生物载体递送平台
Next-Generation Biological Vector Delivery Platform
张玺 深圳市亦诺微医药科技有限公司资本市场副总裁
ZHANG Xi , VP, ImmVira
15:20 - 15:40
项目5
Project 5
AI驱动药物递送和药物发现
AI-Driven Drug Delivery and Drug Discovery
王文首 剂泰医药联合创始人&首席运营官
WANG Wenshou , Co-Founder&COO, METiS Pharmaceuticals
15:40 - 16:00
项目6
Project 6
实体肿瘤细胞药物开发的天科雅方案
TCRCURE Solutions for Solid Tumor
彭玲 天科雅临床副总裁
Lynn PENG , Clinical VP, TCRCURE
16:00 - 16:20
项目7
Project 7
MetCura——致力于为全球抗生素耐药问题提供差异化解决方案
MetCura—Dedicated to Providing Differentiated Solutions to the Global Antibiotic Resistance Problem
邓一军 MetCura首席科学官
DENG Yijun , CSO & Co-Founder, MetCura Pharmaceuticals Inc.
16:20 - 16:40
项目8
Project 8
浙江海昶生物医药技术有限公司——自主知识产权QTsome递送技术平台
Zhejiang Haichang Biotech Co., Ltd.-Independent Intellectual Property Rights of the QTsome Delivery Technology Platform
李剑光 浙江海昶生物医药技术有限公司首席科学家
Robert J. Lee , Chief Scientific Officer, Zhejiang Haichang Biotech Co., Ltd.
16:40 - 17:00
项目9
Project 9
诺纳生物:依托核心技术平台,引领全球下一代生物药创新
Nona Bioscience: Leveraging Industry Leading Platforms to Empower Global Biotherapeutic Innovation
何云 诺纳生物首席技术官
HE Yun , CTO, Nona Biosciences
17:00 - 17:20
项目10
Project 10
基于AIGC新型选择性BTK和JAK3双靶抑制剂候选物WJ1113的发现与生物活性研究
Discovery and Biological Evaluation of Selective BTK and JAK3 Dual-Target Inhibitor Candidate WJ1113 based on AIGC Strategy
汪小涧 中国医学科学院药物研究所研究员
WANG Xiaojian , Professor, the Institute of Materia Medica Chinese Academy of Medical Science